Jump to content

HEL cell line

From Wikipedia, the free encyclopedia
This is the current revision of this page, as edited by WikiCleanerBot (talk | contribs) at 06:24, 9 September 2023 (v2.05b - Bot T20 CW#61 - Fix errors for CW project (Reference before punctuation)). The present address (URL) is a permanent link to this version.
(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

The HEL cell line is an immortalised cell line from a 30-year old male Acute erythroid leukemia patient,[1] used in biomedical research.[2]

HEL cell is capable of induced globin synthesis, producing mainly and chains.[1]

See also

[edit]

Other cell lines in LL-100 panel

References

[edit]
  1. ^ a b Martin, P; Papayannopoulou, T (1982-06-11). "HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression". Science. 216 (4551): 1233–5. Bibcode:1982Sci...216.1233M. doi:10.1126/science.6177045. PMID 6177045.
  2. ^ Quentmeier, H; Pommerenke, C; Dirks, WG; Eberth, S; Koeppel, M; MacLeod, RAF; Nagel, S; Steube, K; Uphoff, CC; Drexler, HG (2019-06-03). "The LL-100 panel: 100 cell lines for blood cancer studies". Scientific Reports. 9 (1): 8218. Bibcode:2019NatSR...9.8218Q. doi:10.1038/s41598-019-44491-x. PMC 6547646. PMID 31160637.
[edit]